CDSCO

AstraZeneca India launches once-daily Xigduo®XR tablets for comprehensive management of type 2 diabetes

Combines two powerful therapies (dapagliflozin and metformin hydrochloride extended-release) to offer comprehensive control of blood sugar with added advantage of…

7 years ago

Multinational companies continue to produce unregulated antibiotics in India

India, February 06, 2018: Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at…

7 years ago